Calendula: the marigold in your diaper cream, examined

Calendula officinalis — the familiar pot marigold you’ll see on cottage-garden lists — has a long history in European folk wound care and is now a common ingredient in diaper creams, dressings and topical balms. Modern research has moved in two directions: mechanistic lab and animal studies that probe cell behaviour and formulation science, and a handful of small human trials. The two streams do not yet converge into a clear clinical picture.

A brief historical frame

References to marigold-based salves stretch back centuries in European herbals, where the plant was used for cuts, abrasions and skin irritation. That long folk record is one reason researchers have repeatedly tested calendula in modern wound models and incorporated it into contemporary dressings and films.

What the lab and animal work shows

Preclinical experiments are the strongest and most consistent part of the evidence base. Topical calendula preparations increase fibroblast proliferation and markers linked to collagen deposition in rodent wound models, and they tend to lower inflammatory markers in treated tissue, findings reported in controlled animal studies and cell-culture work (mice: increased fibroblasts, FGF and hydroxyproline with lower inflammatory markers) (6); rats treated with a calendula-glycolic-alginate hydrogel showed faster wound retraction, less inflammation and greater collagen deposition versus alginate alone (18).^1,2

In vitro studies find that extracts and fractions contain biologically active flavonoids, terpenoids and other compounds, and that calendula-containing materials can promote fibroblast migration or at least are not cytotoxic to fibroblasts in culture (human gingival fibroblasts showed no inhibition of growth with several calendula ethanol extracts) (19). Metabolomic profiling has documented a broad mix of flavonoids, phenolic acids and other constituents that plausibly underlie antioxidant and anti-inflammatory effects (12).^3,4

Beyond simple extracts, a large recent literature explores calendula as a component of engineered dressings and nanoparticles. Calendula-decorated silver nanoparticles, calendula extract in electrospun nanofibers or in bilayer polyurethane dressings, carrageenan films with calendula and honey, and zinc- or silver-containing nanoparticles prepared with calendula extracts all show favourable antioxidant, antibacterial or cell-friendly properties in vitro and in animal implantation models (3,4,11,14,16,21,24). These materials often accelerate closure in scratch assays, reduce bacterial growth in culture, or improve handling and moisture management compared with base polymers (3,4,11,16,24).^{5,6,7,8,9,10,11}

Those formulation studies are useful for biomaterials science, but they do not isolate the effect of calendula itself: when calendula is embedded in a complex dressing or co-formulated with antimicrobial nanoparticles or honey, the observed benefit may be attributable to the carrier, the other bioactives, or to interactions among them rather than to calendula alone.^5,6,7,10

What human studies say — small but suggestive

Human data are sparse and modest in scale. One prospective clinical study compared a calendula tincture with povidone–iodine for postoperative facial wounds in routine practice; it was designed to measure early wound healing scores and infection rates (1). A randomized, double-blind trial examined application of a 10% w/w calendula ointment to one earlobe after bilateral earlobe repair, using the contralateral lobe as control with petroleum jelly; healing and scar outcomes were assessed at 15 days (randomized controlled design) (9).^12,13

A broader systematic review of clinical herbal wound therapies identified multiple small clinical trials of plant-based formulations and listed calendula among species tested in clinical contexts, but the review authors concluded that larger, better‑designed trials are still needed to establish firm clinical recommendations (23).¹⁴

Taken together, human trials suggest possible benefit in specific, short-term wound settings, but the evidence is limited by small sample sizes, heterogeneity of formulations, and inconsistent endpoints. High‑quality, adequately powered trials of calendula versus standard care or placebo are rare.^12,13,14

Formulations drive outcomes — creams, hydrogels and nanoparticles

Most contemporary calendula research focuses on formulation: hydrogels, alginate dressings, carrageenan films, electrospun nanofibers and nanoparticles have all been developed to stabilise calendula constituents and to combine them with antimicrobial metals or other botanicals (5,11,14,3,4). Systematic reviews of plant‑extract hydrogels show calendula as one of the most frequently tested botanicals in that space (5).^5,6,7,8,15

When calendula is one component of a multi‑ingredient dressing, laboratory and animal endpoints look promising — improved fluid handling, antioxidant capacity, reduced bacterial counts in vitro, and faster hemostasis or closure in animal models — but those outcomes cannot prove that calendula alone would have produced the same clinical effect (11,16,21,24).^7,9,10,11

Safety, allergy and practical notes

Published preclinical work shows low cytotoxicity to fibroblasts at typical test concentrations and reports biocompatibility of several calendula‑containing films in implanted animal models (19,11,24). One synthesis study reported no apparent cytotoxicity up to 10 µg/mL and modest cell-migration effects in vitro when calendula was used to make zinc oxide nanoparticles (24).^3,7,11

Two practical cautions: first, many calendula preparations are combined with other active agents, so formulation effects and interactions matter. Second, calendula is in the Asteraceae family; people with known sensitivity to daisies, ragweed or related plants can experience contact allergy to Asteraceae members, so patch-testing or medical advice is sensible when adopting a new topical.

Bottom line for skin and body care

The preclinical dossier for Calendula officinalis — cell work, chemical profiling and multiple animal models — supports plausible mechanisms for reduced inflammation, antioxidant activity and promotion of fibroblast activity and collagen deposition (6,12,19,18).^1,2,3,4

Human clinical evidence is limited but not uniformly negative: a small randomized ear‑lobe trial and other small clinical studies and reviews report potential benefit in specific short‑term wound settings, yet trials are few and heterogeneous in formulation and quality (9,1,23).^12,13,14

If calendula is of interest for routine minor skin use, the best current support is for calendula within well‑engineered dressings or as a topical adjunct in short‑term wound care — always remembering that the formulation and co‑ingredients strongly influence performance. For persistent, infected, or problematic wounds consult a physician or dermatologist; existing trials are not large or consistent enough to replace standard medical care.